{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:20:02Z","timestamp":1769127602636,"version":"3.49.0"},"reference-count":14,"publisher":"Termedia Sp. z.o.o.","issue":"2","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:p>While the management of childhood neutropenia associated with a\u00a0modifiable factor should be appropriate for the primary cause, there are misconceptions regarding the management of severe congenital neutropenia, immune neutropenia and cases classified as \u201cidiopathic\u201d. Antibiotic prophylaxis or granulocyte-colony stimulating factor (G-CSF) are prescribed by specialists in pediatric hematology or immunology, whereas immunization may be conducted by primary care physicians should clear recommendations by provided. There is a\u00a0belief that severe neutropenia, as an immunodeficiency, is associated with compromised effectiveness and increased rate of complications of immunization. The immunization might be delayed or omitted, increasing the risk of unnecessary infection. We discuss the available data and recommendations regarding vaccination of children with chronic severe neutropenia. While there are virtually no studies addressing the safety and effectiveness of vaccination in neutropenia, expert opinions provide information on immunization policy in \u201cphagocytic cells defects\u201d or explicitly neutropenia. There are no contraindications for inactivated vaccines in neutropenia. Live bacterial vaccines are contraindicated. While in general the vaccination with live viral vaccines is encouraged, occasionally neutropenia might be associated with defects of adaptive immunity, which would preclude the administration of such vaccines. Although this should be easily phenotypically identified, we propose assessing immunoglobulin levels and performing a\u00a0low-cost flow cytometry test for major lymphocyte subpopulations to exclude significant defects in adaptive immunity before administration of live viral vaccines to such patients. This can improve the adherence of patients\u2019 guardians and physicians to proposed vaccination policy and the professional and legal safety associated with the procedure.<\/jats:p>","DOI":"10.5114\/ceji.2020.97910","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T03:48:20Z","timestamp":1598413700000},"page":"202-205","source":"Crossref","is-referenced-by-count":2,"title":["Vaccination in children with chronic severe neutropenia \u2013 review of recommendations and a practical approach"],"prefix":"10.5114","volume":"45","author":[{"given":"Szymon","family":"Janczar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Zalewska-Szewczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"B\u0105bol-Pokora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Pa\u015bnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"M\u0142ynarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"ref-1546165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-6-26","article-title":"Congenital neutropenia: diagnosis, molecular bases and patient management","volume":"6","author":"Donadieu J","year":"2011","unstructured":"Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, et al. (2011): Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis 6: 26.","journal-title":"Orphanet J Rare Dis"},{"key":"ref-1546166","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajh.23107","article-title":"Guidelines for pediatric management of severe chronic neutropenia","volume":"87","author":"Dale DC","year":"2017","unstructured":"Dale DC, Boxer LA (2017): Guidelines for pediatric management of severe chronic neutropenia. Am J Hematol 87: 133.","journal-title":"Am J Hematol"},{"key":"ref-1546167","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bjh.14677","article-title":"How I manage children with neutropenia","volume":"178","author":"Dale DC","year":"2017","unstructured":"Dale DC. How I manage children with neutropenia (2017): Br J Haematol 178: 351-363","journal-title":"Br J Haematol"},{"key":"ref-1546168","author":"Sullivan KE","year":"2014","unstructured":"Sullivan KE, Stiehm RE (2014): Stiehm\u2019s Immune Deficiencies. Academic Press."},{"key":"ref-1546169","author":"Rezaei N","year":"2017","unstructured":"Rezaei N, Aghamohammadi A, Notarangelo LD (eds.) (2017): Primary Immunodeficiency Diseases. Springer."},{"key":"ref-1546170","volume-title":"A molecular and genetic approach","author":"Ochs HD","year":"2014","unstructured":"Ochs HD, Smith ECI, Ouck JM (2014): Primary Immunodeficiency Diseases. A molecular and genetic approach. Oxford University Press."},{"key":"ref-1546171","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jpeds.2011.09.019","article-title":"Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia","volume":"160","author":"Boztug K","year":"2012","unstructured":"Boztug K, Rosenberg PS, Dorda M, et al. (2012): Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr 160: 679-683.e672.","journal-title":"J Pediatr"},{"key":"ref-1546172","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla FA","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, et al. (2015): Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 136: 1186-1205.e1181-1178.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1546173","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin LG","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, et al. (2014): 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 58: 309-318.","journal-title":"Clin Infect Dis"},{"key":"ref-1546174","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","article-title":"Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts","volume":"133","author":"Shearer WT","year":"2014","unstructured":"Shearer WT, Fleisher TA, Buckley RH, et al. (2014): Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 133: 961-966.","journal-title":"J Allergy Clin Immunol"},{"key":"ref-1546175","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/j.vaccine.2014.05.022","article-title":"Vaccine use in primary immunodeficiency disorders","volume":"32","author":"Principi N","year":"2014","unstructured":"Principi N, Esposito S (2014): Vaccine use in primary immunodeficiency disorders. Vaccine 32: 3725-3731.","journal-title":"Vaccine"},{"key":"ref-1546176","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2217\/IMT.15.74","article-title":"Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities","volume":"7","author":"Eibl MM","year":"2015","unstructured":"Eibl MM, Wolf HM (2015): Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities. Immunotherapy 7: 1273-1292.","journal-title":"Immunotherapy"},{"key":"ref-1546177","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.vaccine.2016.01.047","article-title":"Adverse events following immunization in patients with primary immunodeficiencies","volume":"34","author":"Sarmiento JD","year":"2016","unstructured":"Sarmiento JD, Villada F, Orrego JC, et al. (2016): Adverse events following immunization in patients with primary immunodeficiencies. Vaccine 34: 1611-1616.","journal-title":"Vaccine"},{"key":"ref-1546178","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14760584.2015.964212","article-title":"Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications","volume":"14","author":"Dub\u00e9 E","year":"2015","unstructured":"Dub\u00e9 E, Vivion M, MacDonald NE (2015): Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines 14: 99-117.","journal-title":"Expert Rev Vaccines"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-90428-129787","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-90428-129787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:35:09Z","timestamp":1767947709000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Vaccination-in-children-with-chronic-severe-neutropenia-review-of-recommendations,90428,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["90428"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2020.97910","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]}}}